[1] HWANG DG, PARK H. Proliferation rates of cancer and normal liver cells under alternative magnetic stimulation[J]. J Korean Magnetics Soci, 2020, 30(5): 162. doi: 10.4283/JKMS.2020.30.5.162
[2] 赵惠柳, 舒宏, 欧超, 等. 原发性肝癌病人血清高尔基蛋白73, 铁蛋白, 甲胎蛋白联合检测的早期诊断价值分析[J]. 蚌埠医学院学报, 2020, 45(2): 112.
[3] LIU L, YANG X, LI NF, et al. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma[J]. Cell Cycle, 2019, 18(21): 2939. doi: 10.1080/15384101.2019.1664223
[4] PIDIKOVA P, SVITOK P, HERICHOVA L, et al. Sex and salt intake dependent renin-angiotensin plasticity in the liver of the rat. [J]. Endocr Regul, 2019, 53(3): 178. doi: 10.2478/enr-2019-0018
[5] 康生朝, 杨婉, 郑英, 等. 苦参碱抑制HepG2肝癌细胞的靶点——ERK信号通路[J]. 肝脏, 2019, 24(2): 187.
[6] QIAN YF, XU WG, WU J. Angiotensin receptor blockers and breast cancer risk: a meta-analysis[J]. Panminerva Med, 2017, 59(3): 269.
[7] LUAN Z, LIU B, SHI L. Angiotensin Ⅱ-induced micro RNA-21 culprit for non-small-cell lung adenocarcinoma[J]. Drug Dev Res, 2019, 80(8): 1031. doi: 10.1002/ddr.21597
[8] MAO Y, PEI N, CHEN X, et al. Angiotensin 1-7 overexpression mediated by a capsid-optimized AAV8 vector leads to significant growth inhibition of hepatocellular carcinoma in vivo[J]. Int J Biol Sci, 2018, 14(1): 57. doi: 10.7150/ijbs.22235
[9] 刘扬, 李竹琴, 张志刚. 去甲肾上腺素及血管紧张素Ⅱ对大鼠心肌细胞胰岛素受体及胰岛素受体底物1酪氨酸磷酸化的综合效应[J]. 蚌埠医学院学报, 2018, 43(2): 146.
[10] HO CM, LEE CH, LEE MC, et al. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin Ⅱ receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study[J]. BMC Cancer, 2018, 18(1): 401. doi: 10.1186/s12885-018-4292-y
[11] DAHER S, MASSARWA M, BENSON AA, et al. Current and future treatment of hepatocellular carcinoma: all updated comprehensive review[J]. J Clin Transl Hepatol, 2018, 6(1): 69.
[12] 蒋智, 张建淮, 屠道远, 等. 肝癌肿瘤标志物的研究进展[J]. 中国临床研究, 2018, 31(2): 270.
[13] TIAN JL, YAO GD, ZHANG YY, et al. Pyran-2-one derivatives from Croton crassifolius as potent apoptosis inducers in HepG2 cells via p53-mediated Ras/Raf/ERK pathway[J]. Bioorg Chem, 2018, 79(1): 355.
[14] XIE YX, LIAO R, PAN L, et al. ERK pathway activation contributes to the tumor-promoting effects ofhepafic stellate cells in hepatocellular carcinoma[J]. Immunol Lett, 2017, 188(1): 116.
[15] ZHANG Q, LU S, LI T, et al. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway[J]. J Exp Clin Cancer Res, 2019, 38(1): 173. doi: 10.1186/s13046-019-1156-5